Introduction
============

Myocardial ischemic disease is a public health concern with an increasing incidence that results in high morbidity and mortality worldwide ([@B48]). The therapeutic methods targeted at recovering blood flow to the ischemic myocardium are frequently applied in clinic. However, the process of reperfusion might trigger additional injury, as evidenced by an extension of the infarct size ([@B32]). It is well-known that oxidative stress is one of the main pathological factors of myocardial ischemic diseases ([@B19]). Oxidative stress mediators, such as ROS release with high concentrations, could inhibit cell proliferation, augment myocardial apoptosis and increase infarct size, which significantly contribute to long-term mortality and chronic heart failure ([@B42]). Thus, exploring anti-oxidative stress agents is a therapeutic opportunity for ischemia diseases.

Disease state is considered as a systemic imbalance in the theory of traditional Chinese medicine (TCM), and TCM could adjust systemic imbalance through the network system of active components aiming at multiple pathways and targets ([@B25]). TCM are drawing increased notice owing to their clinical curative efficacy for a long time. However, the obscure molecular mechanisms impeded their further development. Nowadays, the constant development of network pharmacology and improvement of biological network data have facilitated system level understanding of the interactions of genes, proteins, thus providing the novel approaches for illuminating the underlying mechanisms associated with the therapeutic efficacy of the active components of TCM ([@B24]; [@B33]).

Network pharmacology could exert an influence at several respects in target and pathway identification and drug-target interactions illumination. Many literatures have successfully reported significant biological findings from these networks. Drug-target correlation networks are usually employed to interpret the mechanism of drug's action ([@B12]). Meanwhile, the protein-disease and drug-drug network were also used to find out the relevance between the target proteins and diseases ([@B17]). The theoretical algorithm named as CIPHER has been applied to discern the key targets and pathways ([@B47]). Network pharmacology has become the foundation stone for the elucidation of drugs' mechanisms. Detecting the latent critical targets and signaling pathways for TCM against the diseases via bioinformatic approaches is time saving and efficient.

Sheng MaiSan is a famous traditional Chinese formula for the treatment of cardiovascular diseases in clinic ([@B49]). Many main kinds of chemical ingredients, such as ginsenosides, homoisoflavonoids and lignans, have been reported to be responsible for the pharmacological activities of Sheng MaiSan ([@B46]). Developing a new type of modern drug combination with clear ingredients and controllable quality will be the new direction of TCM research. Meanwhile, it plays an essential role in speeding up the modernization and internationalization of TCM ([@B26]). Recently, we screened a new drug combination (GRS, the proportion as 6:0.75:6) comprising three compounds, including ginsenoside Rb1 (Ginsenosides of Red ginseng-G), ruscogenin (Saponins of Radix ophiopogonis-R), and schisandrin (Lignans of Fructus schisandrae-S), which showed a significant cardioprotective effects in experimental studies ([@B18]). The proportion of the combination was optimized to achieve the highest efficacy, quality stabilization and clinical safety for research ([@B8]). However, the action mode and related signaling pathways against myocardial ischemic diseases of GRS are unknown. Network pharmacology could accelerate the comprehension and predict the potential critical targets and pathways, and the forecasting consequences might provide some clues for further experimental validation.

Therefore, to better understand how the combination GRS affects biological processes, the bioinformatic approach was implemented to illuminate the correlation of the targets and pathways of GRS. The active ingredients in combination GRS targeted numerous essential proteins with a high degree of specificity and with functional contributions to the main signaling pathways at the same time, which led to the new equilibrium of biological system against diseases. Then, the partial predictive results were verified in H9c2 cardiomyocytes stimulated by hypoxia/reoxygenation (H/R). H9c2 rat cardiomyocyte cell line have been widely used as a model for investigation of myocardial ischemic diseases ([@B51]; [@B7]). And we induced injury by H/R, which is more physiologically relevant to mimic ischemia/reperfusion injury to cardiomyocytes *in vivo* ([@B39]). Our results will shed new light on the pharmacological mechanism of the combination derived from Sheng MaiSan and will facilitate an illustration of the detailed mechanisms of myocardial ischemic diseases in the network context, and lay the foundation for the further development of new drug with independent intellectual property.

Materials and Methods {#s1}
=====================

Drugs and Reagents
------------------

GRS was a mixture of ginsenoside Rb1, ruscogenin and schisandrin (6:0.75:6). Schisandrin and ginsenoside Rb1 were obtained from Zelang Bio-Technology Co., Ltd (Nanjing, China). Ruscogenin was seperated in the laboratory and the purity was higher than 99%. Fetal bovine serum (FBS) was received from ScienCell (Carlsbad, CA, USA). Dulbecco's modified Eagle medium (DMEM) was purchased from GIBCO/BRL (Life Technologies, Carlsbad, CA, USA). *N*-acetyl cysteine (NAC) was purchased from Sigma-Aldrich (St. Louis, MO, USA). 3-\[4,5-Dimethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide (MTT) was purchased from AMRESCO (Cleveland, OH, USA). The kits for determination of lactate dehydrogenase (LDH), the malondialdehyde (MDA) and the fluorescent kit for 2′, 7′-dichlorofluorescein diacetate (DCFH-DA) were obtained from Beyotime Institute of Biotechnology (Shanghai, China). Protease inhibitor, RIPA lysis buffer, and enhanced chemiluminescene (ECL) reagent were obtained from Vazyme Biotech (Nanjing, China). Antibody against GAPDH was purchased from Bioworld Technology (St. Louis Park, MN, USA), antibody against JNK, p-JNK, p38, p-p38, ERK1/2, p-ERK1/2 and Jak2, p-Jak2, Stat3, p-Stat3 were obtained from Cell Signaling Technology (Boston, MA, USA).

Construction of the Protein Database
------------------------------------

As reported in our previous studies ([@B45]; [@B21]), the protein database was composed of two parts. **Figure [1A](#F1){ref-type="fig"}** depicts the process of this study. The first part of the database was composed of the known targets, which were retrieved from the literature database^[1](#fn01){ref-type="fn"}^. The search Mesh terms were assigned as "compound name" (\#1 "ginsenoside Rb1," \#2 ruscogenin, \#3 schizandrin, \#4 \#1 NOT \#2 NOT \#3, \#5 \#1 OR \#2 OR \#3). The proteins/genes which accorded with the Mesh terms were collected from the literatures^[2](#fn02){ref-type="fn"}^. The second part consisted the novel proteins related to the compounds with high affinity, which obtained from the PharmMapper database^[3](#fn03){ref-type="fn"}^ ([@B29]). Structures of the three components were established by Sybyl 6.9, and then were employed to all hydrogens and Gastiger-Huckel charges in Sybyl 6.9 in the Tripos force field in an implicit solvent condition ([@B21]). The minimization steps included 1000 cycles of steepest descent until meeting convergent threshold of 0.05 kal-1Å-1 ([@B45]). Then the three compounds were imported into the PharmMapper human protein database, and the top 100 proteins were chosen. Meanwhile, the combined proteins/genes contained in the results were screened with the myocardial ischemic diseases from the OMIM, Genecards and DrugBank database. Protein--protein/gene--gene information included links to databases, such as BIND, BioGRID, DIP, HPRD, IntAct and MINT, which represented the major interactome for further bioinformatics analysis. The proteins/gene/GEO Profiles were standardized in the NCBI database entailed on *Homo sapiens*^[4](#fn04){ref-type="fn"}^.

![**Drug--target interaction network. (A)** The flowchart of model establishing. **(B)** Myocardial ischemic diseases related proteins information statistics. **(C)** The drug--target network of GRS. The red diamond represents ginsenoside Rb1; the yellow triangle represents schisandrin; the green square represents ruscogenin. **(D)** Compound-Myocardial ischemic diseases related protein network. The red diamond represents ginsenoside Rb1; the blue triangle represents schisandrin; the green square represents ruscogenin.](fphar-08-00021-g001){#F1}

The Establishment and Analysis of the Network
---------------------------------------------

The drug-target network was constructed using Cytoscape 2.8.3 ([@B9]). Nodes in the interactome corresponding to the genes and edges represented documented interactions in the visualization. Cytoscape could be download from the website <http://cytoscape.org>. Then the degree and betweenness of the ingredients were analyzed with the Centiscape module in Cytoscape. The most fundamental feature of the node was its degree, which showed how many links the node with other nodes. The betweenness and the degree were the node topological and centric indexes ([@B15]; [@B21]). Higher degree and larger betweenness nodes are most significant ([@B3]; [@B35]).

Network analysis was then subjected to GeneMANIA in Cytoscape, a plugin used for making fast and efficient gene function predictions. GeneMANIA algorithms have been exhibited to be as well as, or better than, in accuracy and speed compared with other gene function prediction algorithms. Furthermore, the GeneMANIA plugin was developed for the consideration and visualization of pathway interaction networks among the genes. The *Homo sapiens* database of GeneMANIA was previously downloaded from the internet, and then gene names were imported into the plugin, followed by selecting the right names and descriptions for them. Finally, the visualization network was represented as the pathway between the interaction genes.

On account of the high degree nodes from drug-target network, the proteins with little biological meanings in functional annotation chart through Biocarta analysis were eliminated ([@B16]). Pathway analysis plays a vital part in detecting potential biological processes that the genes participate in. A variety of databases such as GeneGo, KEGG and Biocarta collect cured pathways ([@B1]). In our current study, the functional annotation clusters were divided into groups of similar annotations employing Biocarta functional annotation tool in accordance with the enrichment scores. Gene ontology (GO), another form of pathway, displays the cellular locations and physiological functions of multiple genes ([@B16]). GO analysis were proceeded using the BINGO 2.4.4 plugin of Cytoscape 2.8.3. The genes were applied to cellular component; molecular function and biological process ontology file analysis.

Cardiomyocytes Culture
----------------------

Rat H9c2 cardiomyocytes was purchased from Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China). The cells were grown in DMEM added with 10% FBS, 100 μg/mL streptomycin and 100 U/mL penicillin at 37°C in a humidified atmosphere containing 5% CO~2~.

H/R Injury Model *In vitro*
---------------------------

The oxygen and glucose deprived (OGD) technique was established according to a previously described protocol ([@B38]). In current investigation, the OGD injury was conducted through supplementing none glucose DMEM and exposed to a hypoxic condition of 94% N~2~, 5% CO~2~ and 1% O~2~ at 37°C in a humidified N~2~/CO~2~ incubator and then in a standard incubator with normal atmosphere at 37°C. H9c2 cardiomyocytes were given with GRS (0.1--10 μg/mL) or *N*-acetyl cysteine (NAC, 500 μmol/L) during the hypoxia. At the beginning of reoxygenation, H9c2 cells were re-exposed to GRS and NAC.

Cell Viability Assay and Measurement of LDH Activity
----------------------------------------------------

H9c2 cardiomyocytes growing exponentially were trypsinized and then approximately 8000 cells/well were seeded into 96-well plates. After the experimental treatment, cells were given with 0.5 mg/mL MTT for 3 h at 37°C. And then the medium was discarded and the formazan crystals was dissolved with DMSO. The absorbance was read at 570 nm with a reference wavelength of 650 nm. The LDH activity was then detected to further investigate the degree of cell injury. At the end of the experiment, the supernatants of culture medium were gathered. The LDH activity was measured at 490 nm following the manufacturer's descriptions.

Measurement of Malondialdehyde (MDA) and Intracellular ROS
----------------------------------------------------------

The content of MDA was determined with assay kits according to the manufacturer's instructions. In brief, cells were harvested by trypsinization and cellular extracts were lysed with RIPA lysis buffer. Then lysed cells were centrifuged and the supernatant were subjected to the measurement of MDA levels and the protein contents. MDA contents were normalized to milligram protein. Additionally, ROS levels were detected using 2′, 7′-dichlorofluorescein diacetate (DCFH-DA). The cardiomyocytes were first incubated with DCFH-DA (10 μmol/L) for 30 min, then washed with PBS and visualized by fluorescence microscopy.

Western Blot Analysis
---------------------

As reported ([@B13]), the H9c2 cardiomyocytes were lysed with RIPA lysis buffer added with protease inhibitor. The cell lysates were then centrifuged and protein concentrations were calculated using a BCA protein assay kit (Beyotime Institute of Biotechnology, Shanghai, China). The equal amounts of protein (40 μg) were separated by denaturing 12.5% SDS-PAGE and transferred onto PVDF membranes. The membranes were then blocked with 3% BSA and incubated with primary antibodies against JNK, p-JNK, p38, p-p38, ERK1/2, p-ERK1/2, Jak2, p-Jak2, Stat3, p-Stat3 and GAPDH (dilution 1:1000, 1:800, 1:1000, 1:800, 1:1000, 1:1000, 1:1000, 1:500, 1:1000, 1:500, 1:8000, respectively) overnight at 4°C. Then membranes were probed with peroxidase conjugated secondary antibody with a 1: 8000 dilution. The antigen-antibody complexes were then tested with ECL reagent and visualized by ChemiDoc^TM^ MP System (Bio-Rad), and analyzed using Image Lab^TM^ Software (version 4.1, Bio-Rad).

Statistical Analysis
--------------------

All experiments were performed in triplicate and the data are expressed as the mean ± SEM. Student's two-tailed *t*-test for comparison between two groups and one-way analysis of variance (ANOVA) were employed for statistical analysis. Dunnett's test was applied when the data involved more groups. *P* \< 0.05 was defined as significant.

Results
=======

Drug-Target Interaction Network
-------------------------------

The characteristics of the drug-target network were shown in **Figure [1B](#F1){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**. Then, we constructed the network of potential targets of the components in GRS by cytoscape, as shown in **Figure [1C](#F1){ref-type="fig"}**. Further, we excluded little biological meaning proteins with Biocarta functional annotation analysis. According to the correlation between proteins with biological meaning, we re-built the protein targets network related to myocardial ischemic diseases of the combination GRS, as illustrated in **Figure [1D](#F1){ref-type="fig"}**. Obviously, the drug-target network was dense and the combination GRS targeted a great deal of proteins. Moreover, the drug-target network results displayed that a single component could act on multiple proteins, while different composition could play a role in the same protein. The link between each component and proteins, protein and protein are close, and the overall correlations are evenly distributed.

###### 

The general network properties of the drug-target interaction network.

  Number of nodes   Number of edges   Average number of neighbors   Network centralization   Characteristic path length   Network heterogeneity
  ----------------- ----------------- ----------------------------- ------------------------ ---------------------------- -----------------------
  268               373               2.784                         0.725                    2.582                        5.250

Evaluation of the Important Proteins
------------------------------------

Through the information technology analysis and forecast of the relationship between protein and protein, we constructed the protein--protein interaction network of the combination targets related with myocardial ischemic disease (**Figure [2A](#F2){ref-type="fig"}**). Then, we selected the essential proteins which have the higher connection degree and larger betweenness from the network (**Figure [2B](#F2){ref-type="fig"}**) for becoming the candidate key proteins, such as NFKB1, JUN, EGF, STAT3, CDH5, HIF1A, FOS, TNF, APP, ESR1, MAPK14, SLC2A1, TP53, MAPK8, all of which were associated with MAPKs, JAK-STAT, oxidative stress and NF-κB signaling pathways and so on (**Table [2](#T2){ref-type="table"}**). Furthermore, we found the protein, which was significantly enriched by analysis of genetic background of the protein in the network, such as STAT3 acceptor, MAP kinase and JNK kinase. The graphical representations of the relative positions of the terms in the GO hierarchy were displayed in **Figures [3A--C](#F3){ref-type="fig"}**, with the extent of importance showed according to color. The major cellular component ontologies (**Figure [3A](#F3){ref-type="fig"}**) were cytoplasmic part, plasma membrane, membrane-bounded organelle, intracellular organelle and interleukin-6 receptor complex. The terms such as regulation of apoptosis, regulation of MAP kinase, inflammatory response, regulation of phosphorylation and regulation of JAK-STAT cascade were significantly enriched in the molecular function ontologies (**Figure [3B](#F3){ref-type="fig"}**). In addition, the enriched biological process ontologies were managed by cytokine receptor binding, stat3 receptor activity, MAP kinase activity, as well as oxidoreductase activity and JUN kinase activity (**Figure [3C](#F3){ref-type="fig"}**).

![**The analysis of interaction network. (A)** The protein--protein interaction network. **(B)** The relationship between node betweenness and degree distribution.](fphar-08-00021-g002){#F2}

###### 

Proteins information of high degree connection and correlation.

  Gene symbol   Betweenness   Degree
  ------------- ------------- --------
  NFKB1         1643.686      193
  JUN           1125.209      207
  EGF           1010.55       79
  STAT3         976.7627      160
  CDH5          778.7818      104
  HIF1A         775.6348      120
  FOS           767.6101      167
  TNF           738.1665      115
  APP           731.193       91
  ESR1          728.0267      112
  MAPK14        697.1574      142
  SLC2A1        672.8005      67
  TP53          660.8239      128
  MAPK8         622.0975      126
  SRC           604.3359      94
  HSP90AA1      581.0109      109
  PRL           580.4675      52
  CSF3          562.9149      82
  CD14          548.6541      88
  MAPK1         537.9401      120
  MAPK3         523.9574      109
  ITGB2         506.0382      103
  MMP9          505.1719      93
  ATF3          500.4878      101
  AKT1          494.9877      114
  IL6           494.3673      120
  CAV1          486.5094      113
  EGR1          484.6549      114
  IL8           482.2064      129
  NFKBIA        458.8095      125

![**Statistical analysis of gene ontology metadata.** Statistical analysis of the gene ontology classification was performed using the BiNGO plugin in cytoscape. The left picture is a graphical representation of top 5 scored -lg (*P*-value) significantly enriched ontologies, presented as the cellular component **(A)**, molecular function **(B)** and biological process **(C)**. The right picture is the enlarged figures including different numbers of top ontologies in the analysis. The orange-marked ontologies in the left are contained in the corresponding right figures.](fphar-08-00021-g003){#F3}

The Pathway Enrichment Analysis
-------------------------------

The top 10 main functional annotation clusters were displayed in **Table [3](#T3){ref-type="table"}** and **Figure [4](#F4){ref-type="fig"}** ranked by the Biocarta functional annotation cluster tool. The functional annotation cluster divided the categories of similar annotations following their enrichment scores. The relevant protein terms in the highest scored cluster were related with the MAPK signaling pathway. The second main pathways related to apoptosis. And the rest clusters on comprised pathways related to Toll-like receptor, Alzheimer's diseases, Dentatorubro pallidoluysian atrophy, Cytokine--cytokine receptor interaction, Amyotrophic lateral sclerosis, Insulin, JAK-STAT and Focal adhesion signaling pathways. On the basis of the enrichment scores, the MAPK signaling pathway was the most possible candidate for GRS function aiming at myocardial ischemic diseases.

###### 

The representive signaling pathways for annotation cluster of GRS.

  Annotation cluster   Signaling pathway
  -------------------- -----------------------------------------
  hsa04010             MAPK signaling pathway
  hsa04210             Apoptosis
  hsa04620             Toll-like receptor signaling pathway
  hsa05010             Alzheimer's disease related pathway
  hsa05050             Dentatorubro pallidoluysian atrophy
  hsa04060             Cytokine--cytokine receptor interaction
  hsa05030             Amyotrophic lateral sclerosis
  hsa04910             Insulin signaling pathway
  hsa04630             JAK-STAT signaling pathway
  hsa04510             Focal adhesion

![**The pathway enrichment analysis.** The Bayes factor quantifying the amount of evidence supporting the hypothesis that the annotation is associated with your gene list. The negative logarithm of the *p*-value calculated from the Bayes factor, calculated using a Fisher's exact test.](fphar-08-00021-g004){#F4}

Experimental Validation
-----------------------

We first examined the effects of different condition of H/R injury on H9c2 cardiomyocytes viability. As shown in **Figure [5A](#F5){ref-type="fig"}**, hypoxia caused a time-dependent decrease in cell viability. Then, the cells were exposed to hypoxia for 6 h, followed by different times of reoxygenation. Adequate cell injury extent was observed at 6 h of reoxygenation (**Figure [5B](#F5){ref-type="fig"}**). Moreover, we detected the viability of cardiomyocytes after the treatment with GRS and GRS at concentrations of 0.1--60 μg/mL did not markedly influence cardiomyocytes viability (**Figure [5C](#F5){ref-type="fig"}**). Then three concentrations (0.1, 1 and 10 μg/mL) were chosen for further detection. H9c2 cardiomyocytes exposed to H/R (H 6 h/R 6 h) led to a decrease in cell viability, while given with 0.1--10 μg/mL GRS and 500 μM positive control drug NAC maintained cell viability (**Figure [5D](#F5){ref-type="fig"}**). As LDH release was an accepted sign for cell injury, the release of LDH in culture medium was determined. LDH release markedly increased after H/R injury as compared to control group, whereas treatment with 0.1--10 μg/mL GRS and 500 μM NAC markedly inhibited the release of LDH (**Figure [6A](#F6){ref-type="fig"}**). These results indicated that GRS had an obvious protective effect against H/R-mediated damage in H9c2 cardiomyocytes.

![**Effects of GRS on H/R induced H9c2 cardiomyocytes injury.** H9c2 cardiomyocytes were exposed to hypoxia followed by reoxygenation. Then the cell viability was detected by the MTT assay described in method. **(A)** Effect of hypoxia on H9c2 cell viability. **(B)** Effect of reoxygenation on H9c2 cell viability. **(C)** Effect of GRS on H9c2 cell viability. **(D)** H9c2 cells were treated with GRS followed by H/R and cell viability was determined by MTT assay. Results were obtained from three independent experiments and were presented as mean ± SEM. ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01 vs. control group without H/R, ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 vs. group treated with H/R alone.](fphar-08-00021-g005){#F5}

![**Effects of GRS on LDH release (A)**, MDA content **(B)** and intracellular ROS **(C)** in H9c2 cardiomyocytes subjected to H/R injury. H9c2 cardiomyocytes were treated with GRS at the concentration of 0.1--10 μg/mL and then exposed to hypoxia of 6 h followed by 6 h reoxygenation. LDH release and MDA content were measured by assay kit. ROS levels were determined using 2′, 7′-dichlorofluorescein diacetate (DCFH-DA, Molecular Probes). NAC was used as a positive control drug. Results were obtained from three independent experiments and were presented as mean ± SEM. ^\#\#^*P* \< 0.01 vs. control group without H/R, ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 vs. group treated with H/R alone.](fphar-08-00021-g006){#F6}

As a significant product of lipid peroxidation, MDA indirectly reveals the generation of intracellular ROS. When cells were subjected to H/R injury, the content of MDA increased remarkably. Whereas, the concentration of MDA significantly decreased after treatment with 0.1--10 μg/mL GRS and 500 μM NAC (**Figure [6B](#F6){ref-type="fig"}**). Meanwhile, compared to the control group, ROS production was markedly increased in the H/R group. While cells treated with GRS showed a substantial reduction in ROS levels (**Figure [6C](#F6){ref-type="fig"}**).

As shown in **Figure [7](#F7){ref-type="fig"}**, we evaluated whether GRS regulated the MAPKs signaling pathway to validate the results from the target-pathway interaction network analysis. The Western blotting results revealed that H/R injury significantly increased phosphorylation of JNK, p38 and ERK1/2 in H9c2 cardiomyocytes, indicating that H/R injury activated MAPKs pathway. While 1--10 μg/mL GRS could down-regulate phosphorylation of JNK, p38 and ERK1/2, and there was no difference in total JNK, p38 and ERK1/2 protein abundance among all groups detected.

![**Effects of GRS on MAPKs signaling pathway in H/R induced H9c2 cardiomyocytes.** H9c2 cardiomyocytes were treated with GRS at the concentration of 0.1--10 μg/mL and then exposed to hypoxia of 6 h followed by 2 h reoxygenation. Protein expressions were detected by western blot. **(A)** Protein expressions of JNK and p-JNK using GAPDH as the loading control. **(B)** Protein expressions of p38 and p-p38 using GAPDH as the loading control. **(C)** Protein expressions of ERK1/2 and p-ERK1/2 using GAPDH as the loading control. Results were obtained from three independent experiments and were presented as mean ± SEM. ^\#\#^*P* \< 0.01 vs. control group without H/R, ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 vs. group treated with H/R alone.](fphar-08-00021-g007){#F7}

In addition, we further investigated whether GRS could regulate the JAK-STAT signaling pathway. As shown in **Figure [8](#F8){ref-type="fig"}**, we found that GRS at the concentration of 10 μg/mL could inhibit the phosphorylation of JAK2 and STAT3 under H/R conditions, suggesting that GRS might play a role in protecting myocardial ischemia injury through the inactivation of JAK2-STAT3 signaling pathway.

![**Effects of GRS on Jak-Stat signaling pathway in H/R induced H9c2 cardiomyocytes.** H9c2 cardiomyocytes were treated with GRS at the concentration of 0.1--10 μg/mL and then exposed to hypoxia of 6 h followed by 2 h reoxygenation. Protein expressions were detected by western blot. **(A)** Protein expressions of Jak2 and p-Jak2 using GAPDH as the loading control. **(B)** Protein expressions of Stat3 and p-Stat3 using GAPDH as the loading control. Results were obtained from three independent experiments and were presented as mean ± SEM. ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01 vs. control group without H/R, ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 vs. group treated with H/R alone.](fphar-08-00021-g008){#F8}

Discussion
==========

Reperfusion-induced oxidative stress is a key contributor to myocardial ischemia-reperfusion (MI/R) injury by inducing a cascade of pathological changes, such as DNA damage, mitochondrial dysfunction and protein aggregation, which in turn lead to cardiomyocytes apoptosis ([@B40]). MI/R-induced redox aberrance results from excessive ROS generation and antioxidant system impairment ([@B6]). Disrupt balance between oxidants and antioxidants lead to uncontrolled myocardial injury. Our study provided evidence that the combination GRS inhibited H/R-induced H9c2 cardiomyocytes injury via potent antioxidant effect as inferred by reduced MDA levels and ROS generation. Whereas, the especial pathway and potential mechanisms has yet to be explored.

As we all know, the complexity of components and obscure mechanisms hinder the development and internationality of TCM in the world. In recent years, network pharmacology has provided an efficient approach for the underlying molecular mechanisms elucidation of TCM. We applied the network of drug-target and target-pathway interaction to discover the potential targets and pathways of the combination of three bioactive components derived from Sheng MaiSan to decipher its mechanism in the treatment of myocardial ischemic diseases.

We found that 30 of nodes with high-degree were existed in the highest annotation cluster pathway. Many pharmacological investigations exhibited that the transcription factor NF-κB exerts an essential part in cell proliferation and serves as an important modulator of the inflammatory process. The activity suppression of NF-κB could protect myocardial ischemia reperfusion induced heart injury ([@B27]). STAT3 has been indicated to be essential for cardioprotective effects such as preservation of LV functional reserve and perfused capillary density, decrease of apoptotic cell death and reduction of infarct size ([@B41]). Moreover, MAPK participated in the regulation of cellular responses to a variety of stimuli, such as mitogens and pro-inflammatory cytokines. Mitogen-activated protein kinases 3, 8 and 14 regulate proliferation, gene expression, cell survival, apoptosis and many other cell functions ([@B36]; [@B22]). The function mechanism of these important proteins might be that they influence the integral network instead of one target alone. The overall network would be disrupt in a pathological state once the critical targets are pulled out from the network. On the contrary, the pathological condition would become normal when very critical proteins aimed at.

Gene ontology has been extensively employed to interpret gene products in any organism as the ontology for designating structural controlled vocabulary terms ([@B21]). And GO is composed of three separate ontologies, including cellular component, molecular function and biological process, which describe the attributes of gene products or gene product group. The three annotation levels were in accordance with signal pathways existed in the functional annotation clusters, which were correlated with the regulation of MAP kinase and the JAK-SATA cascade. This elucidated the action mechanism from the perspective of GO.

Biocarta functional annotation tool was applied to group the functional annotation clusters with similar annotations on the basis of the enrichment scores. The proteins in each groups would be in high relevance with each other. The most essential protein terms in the topmost scored cluster are correlated with the MAPKs signal pathway. Intracellular MAPK (mitogen-activated protein kinase) signaling cascades exert an important part in the pathogenesis of cardiovascular diseases ([@B43]). MAPKs are divided into three subgroups in general: p42/p44 extracellular signal-related kinases (ERK1/2), p38 MAPK, and c-Jun N-terminal protein kinase (JNK) ([@B34]). Reactive oxygen species generated due to ischemia-reperfusion injury could activate MAPKs signaling pathways ([@B11]). When MAPKs were activated, a variety of different substrate proteins were phosphorylated, including essential modulatory enzymes, apoptosis factors and cytoskeletal proteins, through influencing the phosphorylation state of the substrate proteins ([@B50]).

Myocardial ischemia injury activated p38 MAPK, with the transcription factors and protein phosphorylation, increasing adhesion molecule expression and granulocyte activation, eventually leading to myocardial necrosis and apoptosis of large area ([@B30]). Meanwhile, the oxide produced by reperfusion injury could result in JNK MAPK activation, and then activate a variety of transcription factors and trigger programmed cell death ([@B10]). Various studies have demonstrated that targeted inhibition of p38/JNK protect the myocardium from ischemia and reperfusion injury by reducing oxidative stress, inflammation, cardiomyocyte apoptosis, metabolic abnormalities and by maintaining cytoskeletal architecture ([@B20]; [@B11]). In general, the ERK cascade is regarded to participate both cell proliferation and survival. Studies had previously demonstrated that activation of ERK1/2 at the time of myocardial reperfusion confer powerful cardioprotection, indicating a potential amenable pharmacological target for cardioprotection ([@B2]). While latest investigations have verified that, the persistent activation of ERK is also participated in the process of apoptosis ([@B37]; [@B44]). GRS might produced an interlinked network, thus, these building blocks of the body could exert effect as a whole. In the current research, we detected the efficacy of GRS on the expression and activation of MAPKs signaling pathway in H/R-induced H9c2 cardiomyocytes, confirming the forecasting consequences and offering an illustration of the molecular mechanisms of myocardial ischemia diseases. As an active component of GRS, ginsenoside Rb1 has been reported to alleviate the ischemia-reperfusion injury through the inhibition of p38 MAPK and JNK MAPK ([@B23], [@B22]). We found that ruscogenin suppressed mouse neutrophil activation through the inhibited phosphorylation of p38 MAPK, ERK1/2 and JNK ([@B28]). Schisandrin could also exert anti-inflammatory effects via inhibition of JNK and p38 MAPK activities in a RAW 264.7 macrophage cell line ([@B14]).

Due to the large number of literatures with the correlation between the three components in combination GRS and MAPKs signaling pathway, thus, we further investigate whether the combination GRS derived from Sheng MaiSan exerts cardioprotective effects through other novel signaling pathway. Then we focused on the Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling pathway based on the former predicted results. JAK-STAT pathway is a stress-responsive mechanism that delivers signals from the cell surface to the nucleus, hence, regulating gene expression, which plays an essential role in the mechanism of heart diseases with mediating myocardial cell growth, survival and apoptosis ([@B4]). Latest researches have illustrated that ischemia and reperfusion injury in myocardium lead to quick activation of this pathway and activation intervention of this pathway induces the recovery in cardiac function ([@B31]). JAK2 and STAT3 are central component of cardioprotection ([@B5]). In our study, we observed that GRS could markedly inhibit the activation of JAK2-STAT3 signaling pathway. The JAK-STAT signaling pathway is significant for cytokine receptor signaling associated with inflammatory responses. Our investigations demonstrate that the activation of the JAK2-STAT3 signal pathway is possible involved in the emergence and progression of systemic inflammatory response. Therefore, the activation inhibition of JAK2-STAT3 signaling pathways might due to the reduction of inflammatory response. Moreover, the drugs might exerted different effects in different detecting time points and further investigations are needed to explore the underlying protection mechanism in depth. To the best of our knowledge, this is the first study, which illustrates that the regulation of the JAK2-STAT3 pathway exerts a vital part in the pharmacological action of GRS.

Conclusion
==========

The combination of three components derived from Sheng MaiSan appears effective in mitigating H/R-induced H9c2 cardiomyocytes injury via suppression of oxidative stress. Then we applied bioinformatics approach to predict the potential molecular mechanisms of the combination GRS against myocardial ischemia diseases based on an integrated target-pathway interaction network. According to this network, we constructed the molecular targets and signaling pathways correlations between bioactive components and myocardial ischemia diseases. Then we confirmed partial results through experiments in cell model. These outcomes illustrated that the bioinformatics methods were effective in predicting and illuminating the interaction between drug actions and complex diseases. Due to these combined methods, the MAPKs and JAK2-STAT3 signaling pathways were discerned and validated to exert an significant part in the combination GRS mechanism against myocardial ischemia diseases. Further investigations need to proceed more researches of the efficacy of active components on other signaling pathways and their interactions. In addition, the H9c2 rat cardiomyocytes used in our research could not precisely represent cardiac myocytes though it was extensively used in the investigation of cardiovascular diseases. And application of primary cultured cardiac myocyte is in progress to sustain the cardioprotective effect of GRS.
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